These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22615086)

  • 1. Perioperative antiplatelet management in patients with coronary artery stenting.
    Tandar A; Velagapudi KN; Wilson BD; Boden WE
    Hosp Pract (1995); 2012 Apr; 40(2):118-30. PubMed ID: 22615086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary stent management in elective genitourinary surgery.
    Gupta AD; Streiff M; Resar J; Schoenberg M
    BJU Int; 2012 Aug; 110(4):480-4. PubMed ID: 22192977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists.
    Khair T; Garcia B; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2011; 12(2):99-104. PubMed ID: 21421188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-eluting coronary artery stents.
    Dehmer GJ; Smith KJ
    Am Fam Physician; 2009 Dec; 80(11):1245-51. PubMed ID: 19961137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: a review of the current guidelines and literature.
    Lemesle G; Paparoni F; Delhaye C; Bonello L; Lablanche JM
    Hosp Pract (1995); 2011 Oct; 39(4):32-40. PubMed ID: 22056821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].
    Koziński M; Sukiennik A; Sinkiewicz W; Kochman W; Kubica J
    Postepy Hig Med Dosw (Online); 2008 May; 62():185-205. PubMed ID: 18464681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].
    Rossini R; Bramucci E; Castiglioni B; De Servi S; Lettieri C; Lettino M; Musumeci G; Visconti LO; Piccaluga E; Savonitto S; Trabattoni D; Buffoli F; Angiolillo DJ; Bovenzi F; Cremonesi A; Scherillo M; Guagliumi G; ;
    G Ital Cardiol (Rome); 2012; 13(7-8):528-51. PubMed ID: 22781382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents.
    Singh T; Cuomo L; Cohen M; Ahmad HA; Aronow WS
    Curr Clin Pharmacol; 2013 Feb; 8(1):59-66. PubMed ID: 22946865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.
    Faxon DP; Lawler E; Young M; Gaziano M; Kinlay S
    Circ Cardiovasc Interv; 2012 Jun; 5(3):372-80. PubMed ID: 22668555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of antiplatelet agents.
    Mohr TS; Brouse SD
    Orthopedics; 2012 Aug; 35(8):687-91. PubMed ID: 22868592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Rossini R; Musumeci G; Aprile A; Valsecchi O
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of dual antiplatelet therapy following percutaneous coronary intervention with drug-eluting stents: a review of recent evidence.
    Acharjee S; Cannon CP
    Crit Pathw Cardiol; 2010 Dec; 9(4):203-6. PubMed ID: 21119338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.
    Teirstein P; Reilly JP
    J Invasive Cardiol; 2002 Mar; 14(3):109-14. PubMed ID: 11870263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
    Yan BP; Gurvitch R; Ajani AE
    Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy.
    Stone GW; Aronow HD
    Mayo Clin Proc; 2006 May; 81(5):641-52. PubMed ID: 16706262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.